Fulgent Genetics, Inc.
FLGT
$18.59
$0.693.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 95.41% | -11.76% | 22.43% | 12.24% | -437.72% |
| Total Depreciation and Amortization | -5.22% | -7.77% | -2.52% | -3.14% | -33.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.25% | -32.49% | 55.12% | 71.25% | 421.95% |
| Change in Net Operating Assets | 58.23% | -130.44% | -130.11% | 202.40% | -55.59% |
| Cash from Operations | 67.53% | -251.46% | -55.99% | 191.89% | -55.03% |
| Capital Expenditure | -21.64% | -296.85% | -6.59% | -99.41% | 34.22% |
| Sale of Property, Plant, and Equipment | -100.00% | 72.73% | -92.27% | 30.30% | 94.77% |
| Cash Acquisitions | -- | -- | -- | -- | 98.86% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -186.29% | 14.03% | 86.84% | -1,623.11% | 151.65% |
| Cash from Investing | -213.12% | -55.25% | 766.42% | -983.74% | 126.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 93.11% | 92.27% | 96.24% | -287.93% | -754.98% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 98.99% | 84.13% | -134.48% | -119.45% | 18.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98.74% | 87.33% | 92.95% | -154.95% | 12.31% |
| Foreign Exchange rate Adjustments | -192.41% | 235.34% | 95.63% | -346.43% | 151.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.63% | -126.95% | 233.36% | -220.95% | 115.01% |
